PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3328126

Recurrent aneuploidic and euploidic abortion.

P G McDonough
View original source ↗Export metadata ↓

Abstract

The evaluation of recurrent embryopathy in man is one of the most difficult tasks. The physician must clearly recognize which couples are experiencing recurrent euploidic abortion and which couples are experiencing recurrent aneuploidic abortion. A firm knowledge of the cytogenetic character of the abortion material enables one to make the next step, namely to determine the source of error in gametogenesis. Techniques are gradually becoming available to identify the source of the parental gametogenic area. In addition, new methods to detect molecular mutation in euploidic abortion are gradually evolving. The establishment of normal protein profiles by two-dimensional gel electrophoresis in normal abortions should enable one to screen recurrent embryopathy in man for abnormal proteins. Abnormal proteins, once identified, can enable us to identify the specific DNA mutation that may be at the heart of the problem.

Explore related subjects

Abortion, HabitualAneuploidyAnimalsFemaleGenes, LethalHumansMutationPloidiesPregnancyJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P G McDonough. 1987. Recurrent aneuploidic and euploidic abortion.. https://pubmed.ncbi.nlm.nih.gov/3328126/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Human chorionic gonadotrophin (hCG) in the management of recurrent abortion; results of a multi-centre placebo-controlled study.

An international ten-centre double-blind trial comparing hCG with placebo in the management of habitual abortion was conducted. The dose regime for hCG used was 10,000 IU i.m. on first diagnosis of pregnancy, 5000 IU thence twice weekly to week 12, followed by once weekly up to week 16. Identical ampoulage of placebo was used. Seventy-five patients completed the trial. Thirty-six received hCG and thirty-nine placebo. 83% of the pregnancies on hCG were successful compared with 79% on placebo (P = 0.45). Of the 25 defined as having no cause for their habitual abortion history, 83% on hCG were successful, as were 85% on placebo (P = 0.73). No significant differences were found between the two therapies in terms of delivery weight, placental weight or neonatal Apgar score. This study fails to confirm previous promising placebo-controlled data advocating the use of hCG in habitual abortion.

Abortion, Habitual↗
PubMed1992

[The value of anticardiolipin antibody assessment].

Anticardiolipin antibodies (ACL) are associated with the presence of several clinical conditions. To determine the clinical interest of their evaluation, we reviewed all the results of ACL determinations performed in our laboratory during 1990 and 1991. 266 analyses (232 patients) were carried out. Determinations of IgG and IgM type ACL were performed by ELISA. ACL values were positive or slightly positive in 40% of the analyzed samples. Diagnosis was mentioned as the grounds for 212 requests (186 patients). ACL were positive (> m + 3SD) in about 40% of patients with autoimmune disease or with at least two of the following pathologies: autoimmune disease, venous or arterial thromboembolism, recurrent abortion.

Abortion, Habitual↗